About
Drug-polymer conjugate technology, implants
Areas of Focus
Categories
Drug Delivery DeviceDrug Delivery & FormulationAustralia
Team (6)
INTEGRITY & QUALITY
INTEGRITY & QUALITY
PolyActiva
team_member
Integrity & Quality
INTEGRITY & QUALITY
PolyActiva
team_member
LEADERSHIP EXCELLENCE
LEADERSHIP EXCELLENCE
PolyActiva
team_member
Leadership Excellence
LEADERSHIP EXCELLENCE
PolyActiva
team_member
SCIENTIFIC EXPERTISE
SCIENTIFIC EXPERTISE
PolyActiva
team_member
Scientific Expertise
SCIENTIFIC EXPERTISE
PolyActiva
team_member
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
138
By Phase
PHASE1: 6PHASE2: 1
By Status
COMPLETED: 3RECRUITING: 2WITHDRAWN: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06964061Lead Sponsor
Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension
PHASE1Recruiting
12 participants
Started: Jun 10, 2025 · Completed: Nov 15, 2026
NCT06964191Lead Sponsor
Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension
PHASE2Recruiting
75 participants
Started: May 31, 2025 · Completed: Nov 15, 2026
NCT05441930Lead Sponsor
A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery
PHASE1Withdrawn
Started: Jun 23, 2023 · Completed: Mar 14, 2024
NCT05333419Lead Sponsor
Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.
PHASE1Completed
1 participants
Started: Mar 4, 2022 · Completed: Sep 30, 2023
NCT04682288Lead Sponsor
Levofloxacin Ocular Implant for Ocular Surgery
PHASE1Completed
5 participants
Started: Jan 4, 2021 · Completed: Oct 14, 2021
Locations (1)
Headquarters
Notting Hill, Australia
Map
Loading map...